Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

Canadian universities provide world-recognized training in research and leadership for their graduate students...

We would like to update you on new Board of Directors of CBS. As of June 21st 2019, We have President Nima Khadem Mohtaram University of Waterloo 2019 - 2020 President Elect Kibret Mequanint Western University 2019 - 2020 - President 2020-2021 Past President Sophie Lerouge Ecole de Technologie Superieure ETS - CRCHUM 2019-2020 Board Members Fabio Variola University of Ottawa 2019-2021 Isabelle Catelas University of Ottawa 2018-2020 Thomas Willett University of Waterloo 2018-2020 Milica Radisic University of Toronto 2018-2020 Mohsen Akbari University of Victoria 2018-2020 Student Board Member Laura McKiel Queen s University 2019-2020

As you may have noticed already, the WBC2020 Executive Committee is calling for workshop proposals. We hereby would like to take this opportunity to encourage you to submit your proposals before the deadline of June 30th 2019...

Dear CBS members, Our Annual General Meeting will take place during the CBS2019 on May 22nd, at 12 15 in the Suzor Room...

Nanosurfaces have improved the clinical success rate of implants by increasing the rate at which osseointegration is achieved...

Electrospun nanofibrous scaffolds are suitable for tissue engineering as their fibrous structure resembles nano micro fibre-like features of native extracellular matrix ECM , which facilitates cell attachment, growth and proliferation 1 ...

The human mucus layer plays an important role in host defense. In areas such as the airway and gastrointestinal GI tract, the mucus lining acts as a physical barrier to pathogens while providing a microenvironment for commensal bacteria 1 ...

Surface modification constitutes a key strategy for the improvement of blood compatibility for polymeric biomaterials 1 ...

Drug delivery to the brain is severely impeded by the blood brain barrier BBB , preventing the use of most potential regenerative agents for diseases such as stroke...